Dobutamine
Back to searchMolecule Structure
Scientific Name
Dobutamine
Description of the Drug
Dobutamine is a beta-1 agonist used to treat cardiac decompensation in patients with organic heart disease or from cardiac surgery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00841
http://www.drugbank.ca/drugs/DB00841
Brand Name(s)
Not Available
Company Owner(s)
Luitpold Pharmaceuticals Inc, Baxter Healthcare Corp Anesthesia And Critical Care, Hospira Inc, Watson Laboratories Inc, Teligent Pharma Inc, Teva Parenteral Medicines Inc, Eli Lilly And Co, Dr Reddys Laboratories Ltd, Hospira Worldwide, Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL213 |
Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL21237 | |
PharmGKB | PA449381 | |
Human Metabolome Database | HMDB0014979 | |
DrugBank | DB00841 | |
PubChem: Thomson Pharma | 14825296 | |
PubChem | 36811 | |
Mcule | MCULE-6655494898 | |
LINCS | LSM-1807 | |
Nikkaji | J29.869G | J399.069I |
BindingDB | 50325274 | |
EPA CompTox Dashboard | DTXSID3022958 | |
DrugCentral | 937 | |
Brenda | 11198 | 166021 |
ChemicalBook | CB5274062 | |
Guide to Pharmacology | 535 | |
rxnorm | DOBUTAMINE | DOBUTAMINE HYDROCHLORIDE |
KEGG Ligand | C06967 | |
ChEBI | 4670 |